Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.95 | 6.17 | 5.22 |
Stocks | 83.65 | 83.65 | 0.00 |
Bonds | 10.93 | 10.93 | 0.00 |
Other | 4.46 | 4.46 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.69 | 16.28 |
Price to Book | 2.82 | 2.34 |
Price to Sales | 2.26 | 1.81 |
Price to Cash Flow | 11.17 | 10.35 |
Dividend Yield | 2.29 | 2.61 |
5 Years Earnings Growth | 11.28 | 10.79 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 20.99 | 16.90 |
Technology | 18.10 | 18.02 |
Industrials | 12.19 | 13.35 |
Healthcare | 10.99 | 11.93 |
Consumer Cyclical | 8.03 | 10.37 |
Basic Materials | 7.71 | 5.83 |
Consumer Defensive | 7.20 | 7.59 |
Communication Services | 6.61 | 6.47 |
Energy | 6.25 | 4.38 |
Utilities | 1.80 | 4.26 |
Real Estate | 0.12 | 3.61 |
Number of long holdings: 47
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Trojan Ethical Fund O Income | GB00BJP0XY24 | 13.92 | - | - | |
Microsoft | US5949181045 | 3.97 | 412.89 | -0.54% | |
Marsh McLennan | US5717481023 | 3.56 | 206.79 | -0.38% | |
Shell | GB00BP6MXD84 | 3.47 | 33.05 | -0.47% | |
AstraZeneca | GB0009895292 | 3.04 | 12,352.2 | +1.33% | |
Visa A | US92826C8394 | 2.97 | 270.76 | -0.62% | |
Berkshire Hathaway B | US0846707026 | 2.83 | 410.58 | -0.92% | |
Gold Bullion Securities ETC | GB00B00FHZ82 | 2.72 | 215.34 | +0.29% | |
Siemens AG | DE0007236101 | 2.66 | 178.25 | +1.13% | |
Vulcan Materials | US9291601097 | 2.49 | 253.38 | -0.93% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CF Gulland Fund | 5.36M | 4.02 | 1.68 | 6.53 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review